Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form

Medical Mycology

Volumn 43, Issue 5, 2005, Pages 391-396

  D'Auria, F D ^a   Tecca, M ^a   Strippoli, V ^a   Salvatore, G ^b   Battinelli, L ^a   Mazzanti, Gabriela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antifungal activity; Candida albicans; Germ tube; Lavandula angustifolia; Linalool; Linalyl acetate

Indexed keywords

BETA FARNESENE; BORNEOL; CAMPHOR; CARYOPHYLLENE; CARYOPHYLLENE OXIDE; CINEOLE; ESSENTIAL OIL; FLUCONAZOLE; HUMULENE; KETOCONAZOLE; LAVENDER OIL; LIMONENE; LINALOOL; MICONAZOLE; MYRCENE; OCIMENE; TERPINEN 4 OL; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANALYSIS; DRUG DETERMINATION; DRUG EFFICACY; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; GAS CHROMATOGRAPHY; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MYCELIUM; NONHUMAN; OROPHARYNX; STRAIN DIFFERENCE; VAGINA; YEAST;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, CUTANEOUS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; LAMIACEAE; MICROBIAL SENSITIVITY TESTS; MONOTERPENES; PLANT OILS;

CANDIDA ALBICANS; LAVANDULA ANGUSTIFOLIA;

EID: 24644434918     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780400004810     Document Type: Article

References (15)

1. Shimoni M, Putievsky E, Ravid U, Reuveni R. Antifungal activity of volatile fractions of essential oils from four aromatic wild plants in Israel. J Chem Ecol 1993; 19(6): 1129-1133.
2. Muller-Rieban F, Berger B, Yegen O. Chemical composition and fungitoxic properties to phytopathogenic fungi of essential oils of selected aromatic plants growing wild in Turkey. J Agric Food Chem 1995; 43: 2262-2266.
3. Graham C. Complementary therapies: in the scent of a good night's sleep. Nurs Stand 1995; 9: 21.
4. Grieve M. A Modern Herbal. New York: Harcourt, Brace, 1931.
5. Cavanagh HMA, Wilkinson JM. Biological activities of lavender essential oil. Phytother Res 2002; 16: 301-308.
6. Antonov A, Stewart A, Walter M. 1997. Inhibition of conidium germination and mycelial growth of Botrytis cinerea by natural products. Proc. 50th N.Z Plant Protection Conf, 1997: 159-164. http://www.hortnet.co.nz/publications/nzpps/proceedings/97/97_159.pdf
7. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast: Approved Standard, 2nd edn. (Document M27-A2.) Villanova, PA: National Committee for Clinical Laboratory Standards, 2002.
8. Strippoli V, D'Auria FD, Simonetti N. Investigation of the activity by contact of miconazole sulfosalicylate. J Chemother 1990; 2: 371-376.
9. Simonetti N, Strippoli V, Cassone A. Yeast-mycelial conversion induced by N-acetyl-D-glucosamine in Candida albicans. Nature 1974; 250: 344-346.
10. Adams R. (1995). Identification of essential oil components by gas chromatography/mass spectroscopy. Allured Publ. Corp., Carol Stream, U.S.A.
11. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
12. Drago L, Mombelli B, De Vecchi E, et al. Candida albicans cellular internalisation: a new pathogenic factor? Int J Antimicrob Agents 2000; 16: 545-547.
13. Phan RT, Belanger PH, Filler SG. Role of hyphal formation in interactions of C. albicans with endothelial cells. Infect Immun 2000; 68: 3485-3490.
14. Hube B, Naglik J. Candida albicans proteinases. Resolving the mystery of a gene family. Microbiology 2001; 147: 1997-2005.
15. Cutler JE. Putative virulence factors of C. albicans. Annu Rev Microbiol 1991; 45: 187-218.